16_potopnyk
Ser. Khim. 2008. No 49. Part 2. P. 96–101
O ( &
)
Ph-NH-NH2
1) KOH, EtOH
8, X = S, Y = O;
9, X = O, Y = S
10, X = S, Y = O;
11, X = O, Y = S
10 ,
11 13 ,
18–21 . +
R = COOEt (14,18); C(S)NH2 (15,19); CONHPh (16,20);
!
2-( * !+,( $
5+4 1H, ': 1,33 (3 H, CH3,.2,
J = 6,8); 2,06 (3 .,
CH3); 4,20 (2 ., ,.2),
J = 6,8); 6,84 (1 H, Ph); 7,19–7,28 (4 H, Ph); 9,65 (1 H,
, %: C 63,77; H 6,32; N 13,12. C11H14N2O2. )
!
4- * (% !
-1- * !
-1H - ( $ !
-3-
5+4 1H, ': 1,42 (3 H, CH3,.2,
J = 7,2); 4,42 (2 H, CH2),
J = 7,2); 7,40 (1 H, Ph,
J = 7,6); 7,51 (2 H, Ph,
J = 7,6); 7,98 (2 H, Ph,
J = 7,6); 9,17
, %: C 63,27; H 4,84; N 11,02. C13H12N2O3.
(% !
-1- * !
-1H - ( $ !
-3-
5+4 1., ': 7,41 (1 ., Ph,
J = 8,0); 7,53 (2 ., Ph,
J = 8,0);
8,00 (2 ., Ph,
J = 8,0); 9,14 (1 .,
$ !
4-[(1,3-R2-2,4,6- (
" ( +,(
-5(2H )-
% !
]-1- * !
-1 - ( $ !
-3-
&
(6, 7).
4-[(2,4,6- (
" ( +,(
-5(2H )-
! ,
) % !
]-1- * !
-
1 - ( $!
-3- (# " !
(6).
(2 H, CH2)); 7,48 (1 H, Ph); 7,60 (2 H, Ph); 7,85 (2 H, Ph); 8,96 (1 H,
9,67 (1 H, CH=); 11,31 (1 ., NH); 11,37 (1 ., NH). !
!
4-[(1,3- , % !
-2,4,6- (
" ( +,(
-5(2H )-
!
]-1- * !
-1 - ( $ !
-3-
(
2 ), 0,32 (2,0
5+4 1H, ': 1,41 (3 H, CH3,.2); 3,12 (6 ., 2CH3N); 4,41 (2 H, CH2)); 7,49 (1 H,
Ph); 7,60 (2 H, Ph); 7,83 (2 H, Ph); 9,01 (1 H,
, %: C 58,91; H 4,55; N 14,32. C19H18N4O5. )
4-[(4(2)- "
-2(4)-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 -
(10, 11). ,
4-[(4- "
-2-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 - (
-
(10). * . = 235 °,.
4-[(2- "
-4-
"
-1,3-
$ ! ,
-5- ! ,
) % !
]-1- * !
-1 - (
-
(11). * . = 238 °,.
CH3,.2); 4,34 (2 H, CH2)); 7,41 (1 H, Ph); 7,52 (2 H, Ph); 7,92 (2 H, Ph); 8,01
!
4-[(3- % !
-5-
"
-1- * !
-1,5- , +,(
-4 - ( $ !
-4- ! ,
) % !
]-1-
* !
-1 - ( $ !
-3-
(
2 ), 0,7 (4,1
, %: C 68,17; H 4,82; N 13,55. C23H20N4O3. )
18–21.
14 –
17 8
-3- "
-3- "
-1- ( !
)-1- * !
-1 - ( $!
-3- (#
-
(18). * . = 126
– 128 °, (
CH3,.2); 1,43 (3 H, CH3,.2); 4,34 (2 H, CH2)); 4,41 (2 H, CH2)); 7,47 (1 H, Ph);
7,58 (2 H, Ph); 7,89 (2 H, Ph); 8,86 (1 H, CH=); 9,14 (1 H,
-3- "
-1- ( !
)-1- * !
-1 - ( $!
-3- (#
-
(19). * . = 188
– 190 °, (
1,43 (3 H, CH3,.2,
J = 7,2); 4,43 (2 H, CH2),
J = 7,2); 7,11 (1 H, Ph,
J = 7,6); 7,33
(2 H, Ph,
J = 7,6); 7,47 (1 H, Ph,
J = 7,6); 7,60 (2 H, Ph,
J = 7,6); 7,70 (2 H, Ph,
J = 7,6);
7,92 (2 H, Ph,
J = 7,6); 8,75 (1 H, CH=); 9,15 (1 H,
, %: C 67,21; H 4,63; N 14,05. C22H18N4O3. )
4-(3- %
-2- -
"
-1- ( !
)-1- * !
-1 - ( $ !
-3-
(20). * . = 264
– 265 °, ( +60).
(3 H, CH3,.2,
J = 7,2); 4,41 (2 H, CH2),
J = 7,2); 7,46 (1 H, Ph,
J = 7,6); 7,59 (2 H,
Ph,
J = 7,6); 7,89 (2 H, Ph,
J = 7,6); 8,70 (1 H, CH=); 9,16 (1 H,
-2-(4- * !
-1,3- $!
-2- !
) !
]-1- * !
-1 - ( $!
-3- (
-
(21). * . = 196 °, ( +60).
CH3,.2,
J = 7,2); 4,45 (2 H, CH2),
J = 7,2); 7,36 (1 ., Ph); 7,45 (3 ., Ph); 7,60
(2 ., Ph); 7,93 (2 ., Ph); 8,01 (2 ., Ph); 8,12 (1 .,
, %: C 66,84; H 4,03; N 12,86, S 7,42. C24H18N4O2S. )
$
2- * !
-2,6- , +,(
-7H - ( $ !
[3,4-d]
2, 18–21 7
5+4 1.: 7,47 (1 ., Ph,
J = 7,6); 7,58 (2 H, Ph,
J = 7,6); 8,03 (2 ., Ph,
J = 7,6); 8,26 c
1.
Bebernitz G.R., Argentieri G., Battle B., Brennan C., Balkan B., Burkey B.F. et al.
The
Effect of 1.3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice
// J. Med. Chem. 2001. Vol. 44. N 16. P. 2601–2611.
2.
Abadi A.H., Eissa A.A.H., Hassan G.S. Synthesis of novel 1,3,4-trisubstituted pyrazole
derivatives and their evaluation as antitumor and antiangiogenic agents // Chem. Pharm.
3.
Lange J.H.M., van Stuivenberg H.H., Coolen H.K.A.C., Adolfs T.J.P. et al. Bioisosteric
replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and
molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and
selective CB1 cannabinoid receptor antagonists // J. Med. Chem. 2005. Vol. 48. N 6.
4.
Mallegol T., Gmouh S., Meziane M.A.A., Blanchard-Desce M., Mongin O. Practical and
Efficient Synthesis of Tris(4-formylphenyl)amine, a Key Building Block in Materials
Chemistry // Synthesis. 2005. N 11. 4. 1771–1774.
5.
Caluwe P. Heteroannelations with o-aminoaldehydes // Tetrahedron. 1980. Vol. 36.
6.
Denison S., Hilton S.T. A Convenient Synthesis of 2-Cyano-3-Substituted Indoles
// Synlett. 2004. N 15. P 2806–2808.07.12.204
7.
Kira M.A., Abdel-Raemann M.O., Gadalla K.Z. The Vilsmeier
– Haack reaction.
III. Cyclization of hydrazones to hyrazoles // Tetrahedron Lett. 1969. N 2. P. 109–110.
8.
Kira M.A., Aboul-Enein N.M., Korkor K.Z. The Vilsmeier
– Haack reaction. IV. Reaction
of Phosphorus Oxychloride-Dimethylformamide with Semicarbazones // J. Heterocycl.
9.
Brehme R., Gründemann E., Schneider M. Reaktion von Acetophenonmono-methyl-
und -dimethylhydrazonen mit dem Vilsmeier
– Reagenz; Bildung von Pyrazol-4-
carbiminiumsalzen: ein Beitrag zum Mechanismus // J. Prakt. Chem. 2000. Bd. 7.
SYNTHESIS AND CHEMICALS CHARACTERISTICS OF ETHYL
4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE
M. Potopnyk, V. Matiychuk
Ivan Franko National University of Lviv,
Kyryla & Mefodiya Str., 6, 79005 Lviv, Ukraine
Ethyl 4-formyl-1-phenyl-1H-pyrazole-3-carboxylate was synthesized by reaction of ethyl
2-(phenylhydrazono)propanoate with the Vilsmeier–Haack complex. New methods of synthesis of
2-phenil-2,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one were suggested.
Key words : pyrazoles, Vilsmeier–Haack reagent.
Source: http://chem.lnu.edu.ua/visnyk_2008/ORGAN/16_Potopnyk.pdf
IMPORTANT INFORMATION ABOUT TAKING YOUR TRANSPLANT DRUGS After an organ transplant you need to take medication such as ciclosporin or tacrolimus to help prevent you from rejecting that organ. How you take your medication is very important. Below are some key things to remember. For further details or if you have any questions, ask your transplant nurse, doctor or phar
overview of significant cyber warfare events from the newsThis is Cyberthings for Managers, created on Sunday 5th August, 2012, at 10:20 o’clock (GMT+1), reporting onsignificant developments in the world of Cyber warfare, intended for managers. Subscription information in the back. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z |
0-9 |